Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83

Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis

(2019) Patricia Santofimia-Castaño et al.   JOURNAL OF CLINICAL INVESTIGATION

The current state and future perspectives of cannabinoids in cancer biology

(2018) Paweł Śledziński et al.   Cancer Medicine

Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies?

(2017) Attila Keresztes et al.   FEBS LETTERS

A Review of the Therapeutic Antitumor Potential of Cannabinoids

(2017) Višnja Bogdanović et al.   JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids

(2015) Sean D. McAllister et al.   Journal of Neuroimmune Pharmacology

Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma

(2015) E Singer et al.   Cell Death & Disease

Structure–affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist

(2014) Antonella Brizzi et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Cannabidiol as potential anticancer drug

(2012) Paola Massi et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Non-THC cannabinoids inhibit prostate carcinoma growthin vitroandin vivo: pro-apoptotic effects and underlying mechanisms

(2012) Luciano De Petrocellis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy

(2011) A. Shrivastava et al.   MOLECULAR CANCER THERAPEUTICS

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis

(2010) Sean D. McAllister et al.   BREAST CANCER RESEARCH AND TREATMENT

Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis

(2010) Dinesh Thapa et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

(2010) María M Caffarel et al.   Molecular Cancer

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

(2010) R. G. Pertwee et al.   PHARMACOLOGICAL REVIEWS

Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress

(2010) Paola Massi et al.   Cancers

New Resorcinol−Anandamide “Hybrids” as Potent Cannabinoid Receptor Ligands Endowed with Antinociceptive Activity in Vivo

(2009) Antonella Brizzi et al.   JOURNAL OF MEDICINAL CHEMISTRY

Cannabinoids for Cancer Treatment: Progress and Promise

(2008) S. Sarfaraz et al.   CANCER RESEARCH

Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor  -Mediated Ceramide De novo Synthesis in Colon Cancer Cells

(2008) F. Cianchi et al.   CLINICAL CANCER RESEARCH

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors

(2007) S E O'Sullivan   BRITISH JOURNAL OF PHARMACOLOGY

Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1

(2007) Robert Ramer et al.   JNCI-Journal of the National Cancer Institute

Cannabidiol-induced apoptosis in primary lymphocytes is associated with oxidative stress-dependent activation of caspase-8

(2007) Hsin-Ying Wu et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY